Stocktoria

Zura Bio Ltd ZURA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-16

Zura Bio Ltd statistics & valuation

Market cap$333.9M
P / B3.3×
Return on equity-67.6%
Return on capital-74.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
-99.20% -35.30% -67.60% 2022202320242025
Shares outstanding
279720 43.6M 75.1M 94.2M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-489.10% -59.90% -29.20% -60.20% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$141.97 -$2.09 -$0.60 -$1.06 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-60.2%-29.2%-59.9%-489.1%
Return on equity-67.6%-35.3%-99.2%80.3%
Current ratio9.059.164.970.12

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.